LV10386A - Farmaceitiska kompozicija un tas pagatavosanas panemiens - Google Patents

Farmaceitiska kompozicija un tas pagatavosanas panemiens

Info

Publication number
LV10386A
LV10386A LV920547A LV920547A LV10386A LV 10386 A LV10386 A LV 10386A LV 920547 A LV920547 A LV 920547A LV 920547 A LV920547 A LV 920547A LV 10386 A LV10386 A LV 10386A
Authority
LV
Latvia
Prior art keywords
preparation
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
LV920547A
Other languages
English (en)
Other versions
LV10386B (en
Inventor
Kalman Dr Magyar
Jozsef Dr Gaal
Istvan Dr Sziraki
Jozsef Lengyel
Anna Z Szabo
Katalin Marmarosi
Istvan Hermecz
Istvan Dr Szatmari
Zoltan Dr Torok
Peter Dr Kormoczy
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of LV10386A publication Critical patent/LV10386A/lv
Publication of LV10386B publication Critical patent/LV10386B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
LVP-92-547A 1991-12-20 1992-12-20 Pharmaceutical composition and process for the preparation thereof LV10386B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU914060A HUT63579A (en) 1991-12-20 1991-12-20 Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes

Publications (2)

Publication Number Publication Date
LV10386A true LV10386A (lv) 1995-02-20
LV10386B LV10386B (en) 1995-12-20

Family

ID=10966728

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-547A LV10386B (en) 1991-12-20 1992-12-20 Pharmaceutical composition and process for the preparation thereof

Country Status (27)

Country Link
US (1) US5589513A (lv)
EP (1) EP0617615A1 (lv)
JP (1) JPH07502730A (lv)
KR (1) KR940703655A (lv)
AU (1) AU677170B2 (lv)
BG (1) BG98827A (lv)
BR (1) BR9206950A (lv)
CA (1) CA2125776A1 (lv)
CZ (1) CZ147494A3 (lv)
EC (1) ECSP930933A (lv)
EE (1) EE03015B1 (lv)
FI (1) FI942932A (lv)
HU (2) HUT63579A (lv)
IL (1) IL104150A (lv)
LT (1) LT3119B (lv)
LV (1) LV10386B (lv)
MY (1) MY111055A (lv)
NO (1) NO942303D0 (lv)
NZ (1) NZ246384A (lv)
PH (1) PH31073A (lv)
PL (1) PL172048B1 (lv)
RO (1) RO115785B1 (lv)
RU (1) RU2125448C1 (lv)
SI (1) SI9200404A (lv)
SK (1) SK74494A3 (lv)
WO (1) WO1993012775A1 (lv)
ZA (1) ZA929883B (lv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
DE4432610C1 (de) * 1994-09-13 1996-02-01 Knoll Ag Verfahren zur Herstellung von Selegilin-Hydrochlorid
EP0808160A1 (en) * 1995-02-10 1997-11-26 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
JP4499208B2 (ja) 1998-10-29 2010-07-07 株式会社フジモト・コーポレーション 新規な光学活性アミノペンタン誘導体
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
HUP9902482A2 (hu) * 1999-07-22 2002-04-29 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. P-fluoro-selegilin alkalmazása neuroprotektív gyógyszerkészítmények előállítására
EP2053033A1 (en) * 2007-10-26 2009-04-29 Bayer Schering Pharma AG Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
DE102009045056A1 (de) * 2009-09-28 2011-03-31 Henkel Ag & Co. Kgaa Fleckenvorbehandlungsmittel
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity
HU207282B (en) * 1984-05-31 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them
DE3764144D1 (de) * 1986-04-16 1990-09-13 Asta Pharma Ag Synergistische kombination von amantadin und selegilin.
HU207280B (en) * 1986-09-25 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them
HU197510B (en) * 1986-12-19 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
CA2037178A1 (en) * 1990-02-28 1991-08-29 Albert Walter Brzeczko Deprenyl/l-dopa/carbidopa pharmaceutical composition
GB9011767D0 (en) * 1990-05-25 1990-07-18 Britannia Pharmaceuticals Ltd Pharmaceutical compositions
US5169868A (en) * 1991-03-01 1992-12-08 University Of Saskatchewan Aliphatic propargylamines as specific mao-b inhibitors
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
HU209605B (en) * 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
US5326770A (en) * 1992-07-17 1994-07-05 The Du Pont Merck Pharmaceutical Company Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals

Also Published As

Publication number Publication date
KR940703655A (ko) 1994-12-12
SK74494A3 (en) 1995-01-12
PH31073A (en) 1998-02-05
BR9206950A (pt) 1995-11-28
PL172048B1 (pl) 1997-07-31
IL104150A (en) 1997-11-20
WO1993012775A1 (en) 1993-07-08
HU914060D0 (en) 1992-03-30
SI9200404A (en) 1993-06-30
EE03015B1 (et) 1997-08-15
CA2125776A1 (en) 1993-07-08
CZ147494A3 (en) 1995-01-18
AU3265293A (en) 1993-07-28
ZA929883B (en) 1994-05-16
LT3119B (en) 1994-12-27
LV10386B (en) 1995-12-20
NO942303L (lv) 1994-08-17
MY111055A (en) 1999-08-30
LTIP249A (en) 1994-07-15
NZ246384A (en) 1996-02-27
BG98827A (en) 1995-06-30
NO942303D0 (no) 1994-06-17
EP0617615A1 (en) 1994-10-05
JPH07502730A (ja) 1995-03-23
ECSP930933A (es) 1994-04-20
US5589513A (en) 1996-12-31
RU2125448C1 (ru) 1999-01-27
HUT63579A (en) 1993-09-28
HU211478A9 (en) 1995-11-28
AU677170B2 (en) 1997-04-17
FI942932A0 (fi) 1994-06-17
RO115785B1 (ro) 2000-06-30
FI942932A (fi) 1994-06-17

Similar Documents

Publication Publication Date Title
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A (fi) Farmaseuttinen ainekoostumus
DK0515312T3 (da) Farmaceutisk præparat
FI934914A (fi) Farmaceutiska formuleringar
BR1100824A (pt) Composto e composição farmacêutica
FI921060A (fi) Farmaceutiska aerosolformuleringar
DE69224656T2 (de) Arzneimittel
NO923127D0 (no) Farmasoeytisk kombinasjonsformulering
BR9408457A (pt) Preparação farmacêutica percutânia
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
BR9200058A (pt) Composto e composicao farmaceutica
LV10386A (lv) Farmaceitiska kompozicija un tas pagatavosanas panemiens
MX9200622A (es) Composicion farmaceutica
DE4294862T1 (de) Pharmazeutische Komposition
UA26064A1 (uk) Фармацевтичhа композиція
DK0511991T3 (da) Farmaceutisk formulering
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
NZ241331A (en) 3-phenyl-2-alkenamide derivatives and pharmaceutical compositions thereof
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
BR1100486A (pt) Composto e composição farmacêutica
SE9101348D0 (sv) Pharmaceutical composition
SE9103213D0 (sv) Farmaceutisk komposition
NO920564D0 (no) Farmasoeytiske adenosinholdige preparater
ITMI922581A1 (it) Composizione farmaceutica
SE9202820D0 (sv) Farmaceutisk komposition